Open AccessGonadotropin-releasing hormone agonist triggering is effective, even at a low dose, for final oocyte maturation in ART cycles: Case series
Author(s) -
Bülent Gülekli,
Funda Göde,
Zerrin Sertkaya,
Ahmet Zeki Işık
Publication year - 2015
Publication title -
journal of the turkish-german gynecological association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.346
H-Index - 16
eISSN - 1309-0399
pISSN - 1309-0380
DOI - 10.5152/jtgga.2015.15084
Subject(s) - triptorelin , oocyte , gonadotropin releasing hormone agonist , luteal phase , agonist , in vitro fertilisation , medicine , pregnancy , gonadotropin releasing hormone , hormone , andrology , pregnancy rate , in vitro maturation , live birth , endocrinology , biology , luteinizing hormone , embryo , receptor , genetics , microbiology and biotechnology
To investigate the efficacy of low-dose gonadotropin-releasing hormone (GnRH) agonist for final oocyte maturation in females undergoing assisted reproductive treatment (ART) cycles.